CLINICAL TRIALS PROFILE FOR HUMALOG KWIKPEN
✉ Email this page to a colleague
All Clinical Trials for HUMALOG KWIKPEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02971228 ↗ | Feasibility Trial Testing the Bionic Pancreas With ZP4207 | Completed | Beta Bionics, Inc. | Phase 2 | 2016-11-01 | The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207 |
NCT02971228 ↗ | Feasibility Trial Testing the Bionic Pancreas With ZP4207 | Completed | Massachusetts General Hospital | Phase 2 | 2016-11-01 | The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207 |
NCT02971228 ↗ | Feasibility Trial Testing the Bionic Pancreas With ZP4207 | Completed | Zealand Pharma | Phase 2 | 2016-11-01 | The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207 |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HUMALOG KWIKPEN
Condition Name
Clinical Trial Locations for HUMALOG KWIKPEN
Trials by Country
Clinical Trial Progress for HUMALOG KWIKPEN
Clinical Trial Phase
Clinical Trial Sponsors for HUMALOG KWIKPEN
Sponsor Name